Send me a link:

*Text messaging rates may apply.

 Dow Down 1.73% Nasdaq Down 2.02%

Seattle Genetics Inc. (SGEN)

-NasdaqGS
35.10 Down 0.79(2.20%) 3:17PM EDT - Nasdaq Real Time Price
Prev Close:35.89
Open:35.32
Bid:35.25 x 300
Ask:35.26 x 300
1y Target Est:45.15
Beta:1.29
Next Earnings Date:31-Jul-14SGEN Earnings announcement
Day's Range:34.53 - 35.94
52wk Range:32.35 - 55.99
Volume:761,324
Avg Vol (3m):1,079,000
Market Cap:4.32B
P/E (ttm):N/A
EPS (ttm):-0.51
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SGEN

Comparison

Symbol% ChgMkt Cap
SGENDown 2.20%4.32B
IMGNDown 2.97%925.06M
PFEDown 1.69%183.48B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.91
Quarterly EPS Est (Jun-14) :-0.22
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-9.62

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback